Navigation Links
FDA Approves XYZAL(R) For Use In Children Age Six Months And Older For The Relief Of Perennial Allergic Rhinitis And Chronic Idiopathic Urticaria
Date:8/24/2009

i>g information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of sanofi- aventis, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decis
'/>"/>
SOURCE UCB; sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Health Canada Approves Abbotts XIENCE V(R) Drug Eluting Stent
2. First 5 California Approves $81.4 Million Contribution to Help Restore Healthy Families Programs Viability
3. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
4. FDA Approves New 3000 IU Vial Size for Kogenate(R) FS, antihemophilic factor (recombinant)
5. FDA Approves LIVALO(R) for Primary Hypercholesterolemia and Combined Dyslipidemia
6. FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
7. House Committee Approves Amendment Eliminating Cost-Sharing for Medicaid Preventive Services
8. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
9. FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles
10. Kaiser Permanente Approves $11 Million in Community Benefit Grants
11. FDA Approves Expanded Use of Lillys FORTEO(R) [teriparatide (rDNA origin) injection] to Treat Glucocorticoid-Induced Osteoporosis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., LONGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgi...undseniorsinthegreaterLongBeachareathankstoFaithIn...ndependenceatHome(IAH),adivisionofSCANHealthPlan.F...dredsofvolunteerstodeliverwarmThanksgivingmealstos...ay,SouthLosAngelesandsurroundingcities. ,, "Our...
(Date:11/25/2009)..., LOSANGELES,Nov.25/PRNewswire-USNewswire/--The...ionstodetermineexecutiveleadershipfor2010. ,, T...thspecialtiesinpublicpolicy,law,finance,government...ip.TheBoardalsocomesfromawiderangeofpersonalbackgr...en,somelivingwithHIVthemselves,andrepresentingmult...
(Date:11/25/2009)..., BroadPoliticalEndorsements,Business,andPress...Newswire-USNewswire/--Onceagain,theNationalBipolar...mationendorsingtheir"Safe,tilStable"program,whichi...ureforbipolardisorder.Today,theNationalBipolarFoun...ExpressPriorityMailfromtheLt.GovernorofLouisianaMi...
(Date:11/25/2009)...esearchers have found evidence of a statistically ...en among patients whose estrogen receptor (ER)-pos... ER-alpha; at serine-118 (ER-alpha S118-P), accord...mber 25 in the Journal of the National Cancer Ins...s are resistant to tamoxifen. Preclinical studies ...
(Date:11/25/2009)...oes stress increase blood pressure? This simple q... many years. New Stress-related gene Modulates Hi...ease blood pressure? This simple question has bee...ow new research has for the first time established...lood pressure response to stress in mice as well a...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...e than normal birth weight or were not breast-fed ...hers. Researchers from the University at Buff...ociation for Cancer Research annual meeting say th...ost important phase of life for the development of...
...n accepted as a hereditary condition.// Rese...e found out the variety of gene that is responsibl...d down this genetic variance to the gene for andro...sport a head full of hair at sixty. The gene ...
...ted that use of narcotics for chronic pain in elde...creasing the dose. On the other hand, the use of t...crease in the dosage with serious health repercuss...nerve damage, fibromyalgia, arthritis and many suc...
...land had fitted the first ptient with a turbocharg...al device is designed to help patients with modera... go for a heart transplant and its related side ef... The new device is a balloon like structure pr...
...e been able to clone human embryos for creating st...diseases or injury. The newly created stem cell li...immune systems. . This research have provid...ave been found suitable to use in treating patient...
...ational neuroscientist of Vanderbilt University ha...ide an insight into neural circuits that play a ro...eural circuits that make us apply previously learn...will also help the scientists in understanding the...
Other Medicine News:
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeskaCorporation(HSKA);(...specialtyproductstotheveterinaryindustry,announced...hesupplyofbloodgasproductsandaffiliatedconsumables...wscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, ...efieldofadvancedpoint-of-carediagnostics,"commente...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq: ...dtodiscovering,developingandcommercializingnoveldr...forthefiscalyearendedSeptember30,2009.AtSeptember3...entsandshortterminvestments. ,, PipelineUpdate...rial ,, InlateNovember2009,anindependentDataM...
(Date:11/25/2009)...tzerland,Nov.25/PRNewswire/-- FromNovember16-18,Ph...tions,presentedthesecondeditionoftheHearingCarefor...erpopulation.Theconferencebroughttogetherleadingex...han250clinicianswhoworkeverydaywitholderpeoplewith...scussthelatestresearchandtrendsinhearingcareforold...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3QHR and Valley Health Amicably Part Ways 48030 1QHR and Valley Health Amicably Part Ways 48030 2New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 1New Provisional Restorations In Dentistry DVD by Paul R Chalifoux DDS 48026 2Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 1Angelica Corporation Raises Bar Again for Increased Patient Safety 48022 2
...Panelists to Discuss Trends, Trials, and Innovatio... Conferences, CLEVELAND, Sept. 25 Cleveland Clin... on medical innovation and emerging trends,in card...riving the development of new therapies, treat... The 5th annual Cleveland Clinic Medical Inno...
...rena Pharmaceuticals,Inc. (Nasdaq: ARNA ) today a...se 2 clinical trial of APD125 in patients with chr...candidate discovered by Arena that is being,evalua...aining sleep after,initial sleep onset. When compa...ienced statistically significant improvements in m...
Other Medicine Technology:Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 2Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 3Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 4Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 5Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 6Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia 7
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
...atories is a national reference laboratory and a w...and development. ARUP offers an extensive test men...inical and anatomic pathology. Owned by the Univer...ore than half of the nation's university teaching ...
Medicine Products: